Skip to main content
. Author manuscript; available in PMC: 2017 Jan 20.
Published in final edited form as: Breast Cancer Res Treat. 2016 Jan 20;155(2):273–284. doi: 10.1007/s10549-016-3680-8

Table 1.

Treatment schedule for doxorubicin and trastuzumab to evaluate the order of combination dosing: Experiment 4

Groups
Treatments with dosing schedule (days)
Group number (N) Dosing Doxorubicin Trastuzumab Saline
1 (N = 7) Control 0, 3, 4
2 (N = 7) Doxorubicin 4 0, 3
3 (N = 7) Trastuzumab 0, 3 4
4 (N = 7) Doxorubicin 24 h prior to Trastuzumab 0 1, 4
5 (N = 7) Trastuzumab 24 h prior to Doxorubicin 4 0, 3
6 (N = 7) Trastuzumab + Doxorubicin 0, 3 0, 3